Literature DB >> 12011529

Ocular applications of povidone-iodine.

S J Isenberg1, L Apt, D Campeas.   

Abstract

Ocular infections can have devastating consequences and may lead to blindness. Povidone-iodine (PVP-I) has many potential advantages over the currently used drugs, including a broader antibacterial spectrum, it turns the surface of the eye brown for a few minutes, bacterial resistance has not been seen and it is cheaper than other agents. PVP-I has made a significant contribution to pre- and postoperative ocular surgical prophylaxis, ophthalmia neonatorum prophylaxis and treatment of bacterial conjunctivitis. Scientific support for these applications includes studies conducted over the past 17 years, which are reviewed. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011529     DOI: 10.1159/000057733

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  5 in total

1.  Evaluation of corneal damage caused by iodine preparations using human corneal epithelial cells.

Authors:  Yuuka Shibata; Yuta Tanaka; Takashi Tomita; Takanori Taogoshi; Yasuhiro Kimura; Taiichiro Chikama; Kenji Kihira
Journal:  Jpn J Ophthalmol       Date:  2014-09-18       Impact factor: 2.447

2.  Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.

Authors:  Ellen Shorter; Meredith Whiteside; Jennifer Harthan; Mathew S Margolis; Andrew T Hartwick; Spencer Johnson; Mary Migneco; Christina Morettin; Christian K Olson; Julia Huecker; Tammy Than; Mae O Gordon
Journal:  Ocul Surf       Date:  2019-08-08       Impact factor: 5.033

3.  Letter to the Editor: Effect of Povidone Iodine 5% on the Cornea, Vision, and Subjective Comfort.

Authors:  Andrew Hartwick; Ellen Shorter; Mathew Margolis; Spencer Johnson; Tammy Than
Journal:  Optom Vis Sci       Date:  2017-11       Impact factor: 1.973

4.  Prospective study to determine the penetration of iodide into the anterior chamber following preoperative application of topical 1.25% povidone-iodine.

Authors:  Fabian Hansmann; Harald Below; Axel Kramer; Gerald Müller; Gerd Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12-21       Impact factor: 3.535

Review 5.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.